SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $275,000 | +15.5% | 4,500 | +164.7% | 0.01% | 0.0% |
| Q3 2019 | $238,000 | -23.5% | 1,700 | 0.0% | 0.01% | -26.3% |
| Q2 2019 | $311,000 | +15.2% | 1,700 | 0.0% | 0.02% | +11.8% |
| Q1 2019 | $270,000 | +12.5% | 1,700 | 0.0% | 0.02% | +21.4% |
| Q3 2018 | $240,000 | -9.8% | 1,700 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $266,000 | -2.9% | 1,700 | 0.0% | 0.02% | -5.9% |
| Q1 2018 | $274,000 | -2.1% | 1,700 | 0.0% | 0.02% | -5.6% |
| Q4 2017 | $280,000 | – | 1,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |